Stockreport

We Might See A Profit From Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Soon [Yahoo! Finance]

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com
PDF Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. The US$19m market-cap company post [Read more]